Suchergebnisse - "Hanauer, Stephen"

PubPharm (745)

1

Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies

enthalten in: Journal of Crohn's & colitis | 2024

von Verstockt, B. | Pivorunas, V. | Al Mahi, N. | +10

2

Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease

enthalten in: Digestive diseases and sciences | 2024

von Harris, S. | Feagan, B. | Hanauer, S. | +8

3

Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancer

enthalten in: The Journal of clinical investigation | 2024

von Bui, T. | Yalom, L. | Ning, E. | +14

4

Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases

enthalten in: Advances in therapy | 2024

von Kay, J. | Cross, R. | Feldman, S. | +2

5

Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control study

enthalten in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology | 2024

von Aswani-Omprakash, T. | Balasubramaniam, M. | McGarva, J. | +4

6

Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Colombel, J. | Sands, B. | Gasink, C. | +10

ErratumIn: Clin Gastroenterol Hepatol. 2024 Apr 3;:. - PMID 38582496

7

Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients : A Prospective Open-label Study

enthalten in: Journal of Crohn's & colitis | 2023

von D'Haens, G. | Eberhardson, M. | Cabrijan, Z. | +13

CommentIn: J Crohns Colitis. 2023 Dec 30;17(12):1893-1894. - PMID 37738475

8

The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease

enthalten in: Inflammatory bowel diseases | 2023

von Swaminathan, A. | Fulforth, J. | Frampton, C. | +12

9

Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases

enthalten in: Advances in therapy | 2023

von Kay, J. | Cross, R. | Feldman, S. | +2

10

Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease

enthalten in: Journal of Crohn's & colitis | 2023

von Vermeire, S. | Danese, S. | Sandborn, W. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[75]